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1. Size distribution of SMLs of the lipid DPPC by Dynamic Light Scattering (DLS) 
 
 
Figure S1. Size distribution (by intensity) obtained from DLS for solid magnetoliposomes of DPPC 
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2. SEM image of SMLs of the lipid DPPC 
 
 
Figure S2. SEM image (with application of a negative staining) for solid magnetoliposomes of the lipid 
DPPC containing manganese ferrite nanoparticles, showing an aggregate of two magnetoliposomes. 
 
3. Growth inhibitory activity of drug-loaded solid magnetoliposomes 
 
Table S1. Growth inhibitory activity of drug-loaded solid magnetoliposomes on various human tumor 




 (M) for compound 1 GI50 values
a,b
 (M) for compound 2 
DPPC SMLs with 
compound 1 
DPPC/PEG-Fol (95:5) 
SMLs with compound 1 
DPPC SMLs with 
compound 2 
DPPC/PEG-Fol (95:5) 
SMLs with compound 2 
HeLa > 7.5 > 7.5 > 7.5 > 7.5 
MCF7 > 7.5 > 7.5 > 7.5 > 7.5 
T3M4 > 7.5 > 7.5 > 7.5 > 7.5 
NCI-H460 > 7.5 > 7.5 > 7.5 > 7.5 
PLP2 > 7.5 > 7.5 > 7.5 > 7.5 
 
a 
GI50 values correspond to the concentration which inhibited 50% of cell growth. Results are from three 
independent experiments (performed in triplicate). 
b 
Maximum compound concentration tested: 7.5 M. 
 
 
